Background: Given the common elements in the pathophysiological theories that try to
explain the appearance and evolution of obesity and multiple sclerosis, the association …

In the last century, several pandemics were caused by various influenza virus subtypes, with
the Spanish influenza of 1918–1920 being the most severe. 1 Coronaviruses were first …

Objective To evaluate the clinical consequences of extended interval dosing (EID) of
ocrelizumab in relapsing-remitting multiple sclerosis (RRMS) during the coronavirus disease …

Background: Patients affected by different types of autoimmune diseases, including common
conditions such as multiple sclerosis (MS) and rheumatoid arthritis (RA), are often treated …

Background There is no data regarding COVID-19 in Multiple Sclerosis (MS) and
neuromyelitis optica spectrum disorder (NMOSD) patients in Latin America. Objective The …

People with multiple sclerosis (MS) are at risk for infections that can result in amplification of
baseline symptoms and possibly trigger clinical relapses. Vaccination can prevent infection …

The progress in the development of various vaccine platforms against SARS-CoV-2 have
been rather remarkable owing to advancement in molecular and biologic sciences. Most of …

Abstract Introduction The SARS-CoV-2 pandemic necessitated better understanding of the
impact of disease-modifying therapies on COVID-19 outcomes and vaccination. We report …

Background Anti-CD20 antibody therapy may be associated with an increased risk of
infections. We therefore investigated risk factors for infection in patients with demyelinating …

Background The risk of SARS-CoV-2 infection and severity with disease modifying therapies
(DMTs) in multiple sclerosis (MS) remains unclear, with some studies demonstrating …